)
Oncolytics Biotech (ONCY) investor relations material
Oncolytics Biotech AGM 2026 summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Opening remarks and agenda
Meeting called to order by the CFO, with all directors and key management present and introduced.
Voting procedures and virtual participation guidelines explained, ensuring shareholder rights and access.
Notice of meeting and management information circular mailed to shareholders of record.
Shareholder proposals
Three main resolutions presented: Continuance Resolution, Domestication Resolution, and 2026 Incentive Award Plan.
Motions for each resolution were moved and seconded by shareholders.
Q&A with stakeholders
Shareholders and proxy holders could submit questions specific to each resolution during the meeting.
No questions were submitted for any of the motions presented.
- Pivotal data and regulatory filings for late-stage cancer programs are expected imminently.ONCY
H.C. Wainwright 26th Annual Global Investment Conference 20243 Feb 2026 - Advanced pivotal trials for pelareorep in cancer, secured funding, and maintained strong cash position.ONCY
Q2 20242 Feb 2026 - Pelareorep advances toward registration in breast and pancreatic cancers, with new trials and funding needs.ONCY
Canaccord Genuity 44th Annual Growth Conference & Private Company Showcase 20242 Feb 2026 - Pelareorep shows significant survival benefit in breast cancer, advancing toward accelerated approval.ONCY
2024 Cantor Fitzgerald Global Healthcare Conference20 Jan 2026 - Pelareorep delivers strong clinical efficacy and safety in GI cancers, with broad market potential.ONCY
Investor presentation15 Jan 2026 - Pelareorep nearly doubled survival in breast cancer, advancing toward pivotal trials and partnerships.ONCY
Q3 202415 Jan 2026 - Strong clinical progress and prudent financials support pivotal trials and partnerships.ONCY
Q4 202426 Dec 2025 - Biotech firm aims to raise $150M for cancer immunotherapy R&D amid ongoing financial risk.ONCY
Registration Filing16 Dec 2025 - Biotech aims to raise up to C$150M for cancer immunotherapy R&D via shelf equity offering.ONCY
Registration Filing28 Nov 2025
Next Oncolytics Biotech earnings date
Next Oncolytics Biotech earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
Frequently asked questions
Explore our global coverage
)
)